Sanofi India slides as Q2 PAT drops 32% YoY

Image
Capital Market
Last Updated : Jul 27 2022 | 12:16 PM IST

Sanofi India declined 2.63% to Rs 6,430.40 after the company's net profit fell 32.5% to Rs 120.40 crore on 11.4% decrease in net sales to Rs 699.30 crore in Q2 CY22 over Q2 CY21.

Profit before tax slumped 31.7% year on year to Rs 165.80 crore in the quarter ended 30 June 2022.

Total expenses slipped 2.6% to Rs 549.2 crore while cost of raw materials rose 11.9% to Rs 138.80 in Q1 CY22 over Q1 CY21.

Meanwhile, the board approved one-time special interim dividend of Rs 193 per equity share for the year ending 31 December 2022. It has fixed record date as 8 August 2022, for this purpose and the dividend will be paid on or after 22 August 2022.

Sanofi India is one of the entities through which Sanofi operates in India. It offers a wide array of medicines for therapy areas such as diabetes, cardiology, thrombosis, central nervous system and anti-histamines. The products manufactured by the company are distributed in India and exported to many developed as well as developing countries.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 27 2022 | 11:27 AM IST

Next Story